Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies
Sijia Lü, Yibing Wang, Junli Liu
Journal of genetics and genomics/Journal of Genetics and Genomics (2021) Vol. 49, Iss. 4, pp. 269-278
Open Access | Times Cited: 43

Showing 26-50 of 43 citing articles:

Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting
Paula Luque-Linero, Luis Castilla‐Guerra
European Cardiology Review (2024) Vol. 19
Open Access | Times Cited: 1
Investigating the tamoxifen/high-fat diet synergy: a promising paradigm for nonalcoholic steatohepatitis induction in a rat model
Yousra M. Ezz-Eldin, Mohamed G. Ewees, Amany A. Azouz, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 1
Chickpea (Cicer arietinum) protein hydrolysate ameliorates metabolic effects of feeding a high-fat diet to mice
Casey Radlowski, Erick Damián Castañeda-Reyes, Elvira Gonzalezde Mejia
Journal of Functional Foods (2024) Vol. 121, pp. 106407-106407
Open Access | Times Cited: 1
Machine learning based identification potential feature genes for prediction of drug efficacy in nonalcoholic steatohepatitis animal model
Marwa Matboli, Ibrahim Abdelbaky, Abdelrahman Khaled, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Elucidation of the molecular mechanism of type 2 diabetes mellitus affecting the progression of nonalcoholic steatohepatitis using bioinformatics and network pharmacology: A review
Bo Wu, Xiaohong Lan, Ming Gao, et al.
Medicine (2024) Vol. 103, Iss. 37, pp. e39731-e39731
Open Access | Times Cited: 1
2-Geranyl-1-methoxyerythrabyssin II alleviates lipid accumulation and inflammation in hepatocytes through AMPK activation and AKT inhibition
Yiyuan Xi, Soeun Kim, Thuy Thi Thanh Nguyen, et al.
Archives of Pharmacal Research (2023) Vol. 46, Iss. 9-10, pp. 808-824
Closed Access | Times Cited: 3
Effects of curcumin on non-alcoholic fatty liver disease: A scientific metrogy study
Xiankuan Li, Weisan Chen, Jiali Ren, et al.
Phytomedicine (2023) Vol. 123, pp. 155241-155241
Closed Access | Times Cited: 3
Characterization of Pro-Fibrotic Signaling Pathways using Human Hepatic Organoids
Yuan Guan, Zhuoqing Fang, Angelina Hu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Statins as a Potential Treatment for Non-Alcoholic Fatty Liver Disease: Target Deconvolution using Protein-protein Interaction Network Analysis
Ali Mahmoudi, Alexandra E. Butler, Alexander N. Orekhov, et al.
Current Medicinal Chemistry (2023) Vol. 32, Iss. 7, pp. 1355-1377
Closed Access | Times Cited: 2
Network Pharmacology and Molecular Docking Study on the Multi-Target Mechanisms of Aloe vera for Non-Alcoholic Steatohepatitis Treatment
Tấn Khanh Nguyễn, Huy Hieu Phung, Won Jun Choi, et al.
Plants (2022) Vol. 11, Iss. 24, pp. 3585-3585
Open Access | Times Cited: 3
Association between barium exposure and non-alcoholic fatty liver disease in U.S. adults
G Maodong, S. Xin, Jun Luo
Acta Gastro Enterologica Belgica (2023) Vol. 86, Iss. 2, pp. 298-305
Open Access | Times Cited: 1
Proinflammatory interleukins 2, 6 and tumor necrosis factor alpha in patients with hypertension and diabetes mellitus depending on the presence of metabolic-associated liver steatosis
О.М. Radchenko, O.J. Komarytsia, M.O. Borovets, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2024) Vol. 20, Iss. 3, pp. 200-203
Open Access
Risk of myocardial infarction and Osteoporosis: Insights from the 2015–2018 NHANES and Mendelian randomization Studies
Guanmou Li, Bo Peng, Junqiao Fan, et al.
IJC Heart & Vasculature (2024) Vol. 55, pp. 101501-101501
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease in Chronic Hepatitis C Virus Infection: From Basics to Clinical and Nutritional Management
Karina González-Aldaco, Luis A. Torres-Reyes, Claudia Ojeda‐Granados, et al.
Clinics and Practice (2024) Vol. 14, Iss. 6, pp. 2542-2558
Open Access
Exploration on the mechanisms of PuDiLanXiaoYanKouFuYe in the treatment for Helicobacter pylori infections based on network pharmacology
Youhong Hu, Hongci Chen, Ping Yang
(2024), pp. 923-927
Closed Access
Efficacy and Safety of Pentoxifylline on Patients with Non-Alcoholic Steatohepatitis; Randomized Controlled Trial
Ahmed Abomandour, Adel G. Bakr, Ahmed Mohamed ElGhandour, et al.
Research Square (Research Square) (2023)
Open Access
Tilianin alleviates lipid deposition and fibrosis in mice with nonalcoholic steatohepatitis by activating the PPARα/Nnat axis
Ke Fan, Wu Xu, Zheng Jing, et al.
Drug Development Research (2023) Vol. 84, Iss. 5, pp. 922-936
Closed Access
Zarzio Ameliorates Non-alcoholic Fatty Liver Induced By a High Fat Diet in a Rat Experimental Model: A Histological and Immunohistochemical Study
Tourki A. S. Baokbah
International Journal of Morphology (2023) Vol. 41, Iss. 6, pp. 1887-1896
Open Access
MARKERS OF INFLAMMATION IN RATS UNDER TOXIC INJURY AGAINST DIETARY PROTEIN DEFICIENCY
Halyna Kopylchuk, Ivanna Nykolaichuk, M. Nikorych
Biolohichni systemy (2023) Vol. 15, Iss. 2, pp. 109-115
Open Access
Previous Page - Page 2

Scroll to top